Related Experiment Video
Updated: Sep 14, 2025

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.0K
Undiagnosed Hackathon Ends Diagnostic Odyssey in a Patient With DNA2 -Related Rothmund-Thomson Syndrome
Beril Ay1, Ozlem Akgun-Dogan2,3, Fulya Taylan4,5
1School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
American Journal of Medical Genetics. Part A
|July 22, 2025
Summary
Rothmund-Thomson syndrome type 4 (RTS-4) is a rare genetic disorder. This study reports a new patient with RTS-4 outside typical ethnic groups, expanding the known genetic causes and highlighting the importance of genome sequencing.
Area of Science:
- Genetics
- Dermatology
- Ophthalmology
Background:
- Rothmund-Thomson syndrome (RTS) is an ultra-rare genodermatosis with genetic heterogeneity.
- RTS type 4 (RTS-4) is caused by DNA2 gene variants and presents with unique features like microphthalmia and congenital cataracts.
- Previously reported RTS-4 cases involved a specific deep intronic DNA2 variant in individuals of Brazilian/Portuguese descent.
Observation:
- A novel patient with RTS-4 was identified outside of previously described ethnic groups.
- This patient carried the known deep intronic DNA2 variant (ENST00000358410.8:c.588-2214A>G) along with a new pathogenic variant (ENST00000358410.8:c.2519T>C, Leu840Pro).
- The patient's clinical course, including response to recombinant human growth hormone, was documented.
Findings:
- This case expands the known molecular spectrum of RTS-4.
- Genome sequencing was crucial for identifying the deep intronic pathogenic variant.
- The patient remained undiagnosed for several years, underscoring diagnostic challenges.
Implications:
- This finding broadens the ethnic and molecular landscape of RTS-4.
- Highlights the essential role of advanced genetic sequencing in diagnosing rare diseases.
- Emphasizes the value of international collaboration and data sharing in undiagnosed disease research.
Related Concept Videos
Genome-wide Association Studies-GWAS
14.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.3K
Karyotyping
62.4K
Overview
62.4K

